218 results on '"Tsai, Jen-Wei"'
Search Results
2. Systematic Characterization of the Clinical and Pathological Features of Schwannomas Harboring SH3PXD2A::HTRA1 Fusion
3. Extraskeletal Myxoid Chondrosarcomas: The Uncommon Clinicopathologic Manifestations and Significance of TAF15::NR4A3 Fusion
4. Identification of COL1A1/2 Mutations and Fusions With Noncoding RNA Genes in Bizarre Parosteal Osteochondromatous Proliferation (Nora Lesion)
5. Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements
6. Frequent overexpression of klotho in fusion-negative phosphaturic mesenchymal tumors with tumorigenic implications
7. Molecular Characterization of Dermatofibrosarcoma Protuberans: The Clinicopathologic Significance of Uncommon Fusion Gene Rearrangements and Their Diagnostic Importance in the Exclusively Subcutaneous and Circumscribed Lesions
8. Tumor-Induced Osteomalacia Treated as Ankylosing Spondylitis and Osteoporotic Compression Fracture
9. Tumor-Induced Osteomalacia Treated as Ankylosing Spondylitis and Osteoporotic Compression Fracture
10. The immune microenvironment of uterine adenosarcomas
11. Xanthoma of the Bone Mimicking Malignant Bone Tumor with Secondary Aneurysmal-Cystic Change: A Case Report
12. Data from Analysis of HSP27 and the Autophagy Marker LC3B+ Puncta Following Preoperative Chemotherapy Identifies High-Risk Osteosarcoma Patients
13. Supplemental Tables S1-S5 and Figures S1-S5 from Analysis of HSP27 and the Autophagy Marker LC3B+ Puncta Following Preoperative Chemotherapy Identifies High-Risk Osteosarcoma Patients
14. NAB2–STAT6 fusion types account for clinicopathological variations in solitary fibrous tumors
15. Figure-S3 from ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance
16. Supplementary Methods-S1-15 and Tables-S1-4 from ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance
17. Supplementary Figure legends-S1-6 from ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance
18. Dunaliella salina Alga Protects against Myocardial Ischemia/Reperfusion Injury by Attenuating TLR4 Signaling
19. Id1 promotes lung cancer cell proliferation and tumor growth through Akt-related pathway
20. NAB2-STAT6 gene fusion and STAT6 immunoexpression in extrathoracic solitary fibrous tumors: the association between fusion variants and locations
21. Prognostic implication of MET overexpression in myxofibrosarcomas: an integrative array comparative genomic hybridization, real-time quantitative PCR, immunoblotting, and immunohistochemical analysis
22. Combined Erdheim-Chester disease and Langerhans cell histiocytosis of skin are both monoclonal: A rare case with human androgen-receptor gene analysis
23. Clinicopathological and genetic heterogeneity of the head and neck solitary fibrous tumours: a comparative histological, immunohistochemical and molecular study of 36 cases
24. Three-dimensional multielectrode-controlled two orthogonal direction bendable IPMC actuator with an active clasp
25. Immunohistochemistry Helps to Distinguish Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features/Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma with Other Follicular Thyroid Lesions
26. Cordyceps sinensis protects against renal ischemia/reperfusion injury in rats
27. Recurrent Amplification at 7q21.2 Targets CDK6 Gene in Primary Myxofibrosarcomas and Identifies CDK6 Overexpression as an Independent Adverse Prognosticator
28. Micromachined optical fiber enclosed 4-electrode IPMC actuator with multidirectional control ability for biomedical application
29. Prognostic Implication of Ezrin Overexpression in Myxofibrosarcomas
30. Morphologic Spectrum of Lymphadenopathy in Adult-onset Immunodeficiency (Anti-interferon-γ Autoantibodies)
31. Angiomatoid fibrous histiocytoma: clinicopathological and molecular characterisation with emphasis on variant histomorphology
32. Plasmacytoid urothelial carcinoma: First case reported in the ureter
33. Bilateral Renal Myxoid Perineuriomas
34. Prolonged preoperative fasting induces postoperative insulin resistance by ER-stress mediated Glut4 down-regulation in skeletal muscles
35. Composite haemangioendothelioma: report of four cases with emphasis on atypical clinical presentation
36. Clinicopathological and molecular characterisation of USP6 ‐rearranged soft tissue neoplasms: the evidence of genetic relatedness indicates an expanding family with variable bone‐forming capacity
37. Hernia Uterine Inguinale and Seminoma in Persistent Müllerian Duct Syndrome
38. Optimization of epirubicin nanoparticles using experimental design for enhanced intravesical drug delivery
39. MAGE-A3 Is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma
40. The expanding morphological and genetic spectrum ofMYOD1‐mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non‐mutated cases
41. Clinicopathological and molecular characterisation of USP6‐rearranged soft tissue neoplasms: the evidence of genetic relatedness indicates an expanding family with variable bone‐forming capacity.
42. Osteosarcoma arising from preexisting Paget's disease of bone
43. Cervical cancer with breast metastasis
44. A rare presentation of clinically intractable hypertension: Pancreatic paraganglioma
45. The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma
46. Analysis of HSP27 and the Autophagy Marker LC3B+ Puncta Following Preoperative Chemotherapy Identifies High-Risk Osteosarcoma Patients
47. Abstract B27: Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy
48. Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy
49. Phosphorylated heat shock protein 27 as a potential biomarker to predict the role of chemotherapy-induced autophagy in osteosarcoma response to therapy
50. Abstract 5072: Inhibition of EZH2 as a therapeutic strategy for osteosarcoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.